ICVX — Icosavax Cashflow Statement
0.000.00%
Last trade - 00:00- $766.88m
- $537.68m
- $0.58m
- 37
- 21
- 78
- 42
Annual cashflow statement for Icosavax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -5.3 | -18.9 | -67 | -91.8 |
| Depreciation | ||||
| Non-Cash Items | 0.072 | 0.487 | 30.3 | 20.2 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.656 | 4.16 | -1.91 | 9.06 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -4.57 | -14.2 | -38.5 | -61.7 |
| Capital Expenditures | 0 | -0.011 | -1.01 | -11.1 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | — | -158 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | 0 | -0.011 | -1.01 | -169 |
| Financing Cash Flow Items | — | — | 191 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 26.7 | 6.64 | 305 | 10.3 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 22.2 | -7.58 | 265 | -221 |